Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (2019) - Financial and Strategic Analysis ReviewZhejiang Hangzhou Xinfu Pharma Co., Ltd. (Xinfu), a China-based public share holding company is engaged in production and sale of fine chemical and health care products. It principally focuses in manufacturing range of products including Fine Chemical products; Feed Additive and Animal Health Food Additives and Human Consumption; and Environment Conservation...more
Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis ReviewZhejiang Hisoar Pharmaceutical Co.,LTD. (Hisoar), a public share holding company is engaged in the production and sale of drug substances and drug intermediates. The company principally operates in China and also has global presence offering various active pharmaceutical ingredients and intermediates for human as well as veterinary. Hisoar's range of products...more
PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis ReviewPT. Pyridam Farma Tbk. (Pyridam) is a pharmaceutical company engaged in the manufacture of cosmetics, food supplements, over the counter (OTC) and prescription drugs. The pharmaceutical formulations of the company are manufactured in the form of tablets, caplets, capsules, syrups, creams and ointment. It also produces prescription drugs such as penicillin and non-penicillin antibiotics, anti-tuberculosis, painkillers, and non-prescription products such as vitamins, flu and cough preparations, and antipyretics. Pyridam is also into marketing of medical supply products that include laboratory reagents and disposable medical supplies.This comprehensive SWOT profile of PT. Pyridam Farma Tbk. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part...more
SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis ReviewSemBioSys Genetics Inc. (SemBioSys) is a palnt biotechnology company, that is engaged in the development of pharmaceutical and non-pharmaceutical products to treat various disorders. The company is focused on the development of cost effective production solution targeting...more
Pharmesis International Ltd. (P31) - Financial and Strategic Analysis ReviewPharmesis International Ltd. (Pharmesis) is a pharmaceutical company that manufactures western medicine and traditional Chinese medicine principally for the treatment of liver and gall bladder disorders. The company is also focused on the research and development,...more
Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis ReviewZhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), a China-based public share holding company is engaged in the manufacture and sale of bulk drugs. It principally focuses in providing drugs used in antineoplastics, cardiovascular treatment, anti-infection, anti-parasite, endocrine control, immunoinhibitors and also anti-depression. The company distributes its products in domestic markets as well as overseas markets. It is highly active in research and development concentrating on chemical synthesis, microorganism fermentation, biotechnology, natural plant extraction and preparation development. Currently, Hisun owns five subsidiaries and is headquartered in Tai Zhou, ChinaThis comprehensive SWOT profile of Zhejiang Hisun Pharmaceutical Co. Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your...more
Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis ReviewTianjin Tasly Pharmaceutical Co. Ltd. (Tasly) is a pharmaceutical company engaged in the development, manufacturing and distribution of chemical medicine,...more
Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis ReviewSuven Life Sciences Ltd. (Suven) is a biotechnology company engaged in the business of design, manufacture and supply of bulk actives, drug intermediates and fine chemicals,...more
Welichem Biotech Inc. (WBI) - Financial and Strategic Analysis ReviewWelichem Biotech Inc. (Welichem, formerly known as Welichem Technology Corporation) is a public share holding company. It is principally engaged in the discovery, research and...more
Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic Analysis ReviewAdeona Pharmaceuticals, Inc. (Adeona), public shareholding company is a development-stage specialty pharmaceutical company. It principally focuses on the treatment of...more
Tianjin Zhongxin Pharmaceutical Group Corporation Limited (T14) - Financial and Strategic Analysis ReviewTianjin Zhongxin Pharmaceutical Group Corporation Limited (TZPG) is a pharmaceutical company, engaged in the production and sale of Chinese...more